SCYNEXIS INC.
SCYNEXIS INC.
- USD (-)
- 15 min delayed data - NASDAQ Stocks
Open: -
Change: -
Volume: -
Low: -
High: -
High / Low range: -
Type: Stocks
Ticker: SCYX
ISIN:

SCYNEXIS, Inc. to Present at Upcoming Investor Conferences

  • 25
SCYNEXIS, Inc. to Present at Upcoming Investor Conferences

PR Newswire

JERSEY CITY, N.J., Nov. 20, 2018 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced that the Company will present at the following upcoming investor conferences:

  • The 30th Annual Piper Jaffray Healthcare Conference at the Lotte New York Palace Hotel on Tuesday, November 27, 2018 at 10:10 a.m. ET.
  • The Evercore ISI HealthConX Conference at the Boston Harbor Hotel on Wednesday, November 28, 2018 at 11:45 a.m. ET.

Live webcasts of the presentations will be available on the Investors section of the Company's website: www.scynexis.com. Replays of the presentations will be available approximately two hours after each event and will be available for two weeks following each presentation.

About SCYNEXIS
SCYNEXIS, Inc. (NASDAQ:SCYX) is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing innovative therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas. SCYNEXIS's lead product candidate, ibrexafungerp (formerly SCY-078), is a novel oral/IV antifungal agent in Phase 2 clinical and pre-clinical development for the treatment of multiple serious and life-threatening invasive fungal infections caused by Candida and Aspergillus species. For more information, visit www.scynexis.com.

CONTACT:

Investor Relations
Natalie Wildenradt
Argot Partners
Tel: 212-600-1902
[email protected]

Media Relations
George E. MacDougall
MacDougall Biomedical Communications
Tel: 781-235-3093
[email protected]

Cision View original content:http://www.prnewswire.com/news-releases/scynexis-inc-to-present-at-upcoming-investor-conferences-300753206.html

SOURCE SCYNEXIS, Inc.

PR Newswire
PR Newswire

PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.